The U.S. Food and Drug Administration (FDA) has announced that bemotrizinol has been added to the list of permitted over-the-counter (OTC) sunscreen active ingredients. The new FDA approval for sunscreen ingredient Bemotrizinol could introduce the American with a safer and more effective protection.
Bemotrizinol has already been widely used in Europe, Australia, and several Asian countries. However, according to the FDA, bemotrizinol is the first new active ingredient added to the OTC sunscreen monograph since the late 1990s, which is more than two decades.
The FDA approval for sunscreen ingredient Bemotrizinol marks a significant milestone for consumer health in the United States.
What Is New Sunscreen Ingredient Bemotrizinol?
Bemotrizinol is a chemical UV filter designed to protect the skin from harmful ultraviolet radiation. Unlike some existing sunscreen ingredients, it provides broad-spectrum protection against both ultraviolet A (UVA) and ultraviolet B (UVB) rays.
UVA rays are associated with premature skin aging and wrinkles, while UVB rays are the primary cause of sunburn. Both types of radiation contribute to skin cancer risk.
Bemotrizinol offers several potential advantages:
- Broad-spectrum UVA and UVB protection
- High photostability, meaning it remains effective when exposed to sunlight
- Low levels of skin absorption
- Greater flexibility for sunscreen product formulation
According to the FDA’s review, bemotrizinol demonstrates low absorption through the skin and meets safety and effectiveness standards for use in adults and children aged six months and older.
The FDA approval for sunscreen ingredient bemotrizinol introduces a UV filter to the United States, already familiar to many global sunscreen manufacturers.
About The FDA Bemotrizinol Approval
The FDA completed the new sunscreen ingredient review under the streamlined process established by the CARES Act, which modernized how certain nonprescription drugs are evaluated.
The ingredient, Bemotrizinol, was proposed for approval in December 2025 following a request submitted by DSM Nutritional Products LLC. After reviewing public comments and scientific evidence, the FDA issued its final permit order leading to the FDA approval for sunscreen ingredient Bemotrizinol at concentrations of up to 6%.
“This is exactly the kind of progress we can achieve when we modernize our processes and apply sound science to regulatory decisions,” said Mike Davis, M.D., Ph.D., Acting Director of the FDA Center for Drug Evaluation and Research.
Changes in FDA Sunscreen Regulation
After the review, certain changes to FDA sunscreen regulation were introduced through the OTC monograph reform process.
Under this framework, sunscreen products can enter the market without a separate drug application if they comply with conditions established in the OTC monograph. The FDA can update these requirements through administrative orders when new scientific evidence becomes available.
In its final decision, the agency determined that bemotrizinol is generally recognized as safe and effective (GRASE) for approved uses. This FDA approval for sunscreen ingredient Bemotrizinol allows manufacturers to incorporate the ingredient into products that meet FDA requirements.
How The New Sunscreen Ingredient Affects The US Market
Due to its strong UVA protection profile and established international safety record, FDA approval for sunscreen ingredient Bemotrizinol could influence product development across the U.S. sunscreen market.
Manufacturers now have access to an additional UV filter that may help improve sunscreen formulations and expand consumer choice. Increased competition could also encourage further innovation among companies developing sun protection products.
According to DSM-Firmenich, products containing bemotrizinol are expected to reach consumers by the end of 2026.
The approval may also help narrow a long-discussed gap between the United States and international markets, where newer UV filters have often become available sooner.
Conclusion
The addition of bemotrizinol represents one of the most significant updates to the list of FDA-approved sunscreen ingredients in decades. While consumers will not see immediate changes on store shelves, the decision opens the door for future product launches featuring the ingredient.
As regulators continue evaluating new technologies and scientific evidence, the FDA approval for sunscreen ingredient Bemotrizinol may influence future sunscreen innovation in the United States.
For Americans, the new sunscreen could provide effective sun protection options while maintaining established safety standards this summer.
